Conmed (NYSE:CNMD) reported quarterly earnings of $0.89 per share which beat the analyst consensus estimate of $0.82 by 8.54 percent. This is a 6.32 percent decrease over earnings of $0.95 per share from the same period last year. The company reported quarterly sales of $317.046 million which beat the analyst consensus estimate of $310.507 million by 2.11 percent. This is a 1.32 percent decrease over sales of $321.300 million the same period last year.